Two Oral Cancer Drugs Effective in ‘Steve Jobs’ Disease (CME/CE)

(MedPage Today) — Two small-molecule kinase inhibitors appear to be effective at extending progression-free survival in pancreatic neuroendocrine tumors, researchers say.

Post a Comment

Comments are closed.